Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Cannabis banking legislation moves forward in US Senate

Published 09/27/2023, 10:53 AM
Updated 09/27/2023, 12:02 PM
© Reuters. Recreational cannabis products are for sale during the opening of a marijuana dispensary by NativeCare, owned by the Red Lake Nation and located on their rural reservation, in Red Lake, Minnesota, U.S. August 1, 2023. REUTERS/Erica Dischino/ File Photo

By Arunima Kumar and Sourasis Bose

(Reuters) -A U.S. Senate committee on Wednesday voted to advance a marijuana banking bill, raising hopes for the cash-dependent cannabis sector to get access to regular banking services.

The Secure and Fair Enforcement Regulation Banking Act (SAFER) bill, introduced by a bipartisan group of senators last week, will now move to the Senate floor.

Most banks in the country do not service cannabis companies as marijuana remains illegal at the federal level despite several states legalizing its medicinal and recreational use.

The new bill seeks to ensure that all businesses — including state-sanctioned cannabis businesses — will have access to deposit accounts, insurance and other financial services.

Shares of SNDL, Trulieve Cannabis (OTC:TCNNF), Cronos Group (NASDAQ:CRON) rose between 1% and 3% following the vote.

U.S. cannabis-related ETF AdvisorShares Pure US Cannabis ETF gained 1.4%.

"We are hopeful that the revised language and clearer guidelines for financial institutions will continue to break through the many unproductive hurdles that have prolonged the passage of this bill for far too long," said cannabis firm Acreage Holdings (OTC:ACRGF).

An earlier version of the bill, the SAFE Banking Act, had failed to secure a Senate vote despite the House of Representatives passing it seven times.

"Realizing this first vote out of the Senate signals strong bipartisan support from both chambers of Congress," said Trulieve CEO Kim Rivers.

Last month, the U.S. Department of Health and Human Services (HHS) recommended easing restrictions on marijuana. The agency suggested classifying the substance to a Schedule III drug from Schedule I.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The recommendation was provided to the Drug Enforcement Agency, which has the final authority on rescheduling.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.